COR Cencora, Inc.

341.25USD-2.03%Mkt Cap: 65.12B USDP/E: 19.01

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap65.12B USD
Enterprise Value72.85B USD
Revenue (TTM)337.40B USD
Gross Profit13.80B USD
Net Income (TTM)3.48B USD
Revenue/Share1746.56 USD
Last Price341.25 USD
Fiscal Year EndSep 2026
MR QuarterSep 2026
Employees—
CountryUS
SectorHealthcare
IndustryMedical Distribution
ISIN—
Valuation
P/E (Trailing)19.01
P/E (Forward)15.70
PEG0.77
EV/EBITDA12.74
EV/Revenue0.22
P/S0.19
P/B17.69
EPS (TTM)17.95 USD
EPS (Forward)21.71 USD
52W Range
244.8273% of range377.54
52W High377.54 USD
52W Low244.82 USD
Profitability
Gross Margin4.09%
Oper. Margin1.39%
EBITDA Margin1.70%
Profit Margin1.03%
ROE129.01%
ROA3.57%
ROIC—
ROCE—
Growth
Revenue Growth5.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF3.88B USD
CapEx (TTM)667.98M USD
FCF Margin0.53%
FCF Yield2.75%
Net Debt6.39B USD
Net Debt/EBITDA1.12
Net Debt/FCF3.57
Balance Sheet
Debt/Equity5.08
Current Ratio0.94
Quick Ratio0.50
Book Value/Sh19.29 USD
Cash/Share25.57 USD
Dividends
Fwd Div Rate2.64 USD
Trail. Div Rate2.40 USD
Div. Yield0.76%
5Y Avg Yield0.90%
Payout Ratio17.45%
Ex-Div DateNov 13, 2026
Pay DateNov 30, 2026
Splits
Last Split2:1
Split DateJun 16, 2009
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)388.25 USD
Upside (mean)+13.8%
Target Range330.00 USD – 415.00 USD
330.00+13.8% to mean415.00
# Analysts12
Ownership
Shares Out.190.83M
Float180.21M
Insiders4.36%
Institutions97.93%
Short Interest
Short Ratio2.6d
Short % Float1.88%
Short % Out.1.65%
Shares Short3.16M
Short (prev mo.)3.92M
Technical
SMA 50327.68 (+4.1%)
SMA 200316.70 (+7.8%)
Beta0.57
S&P 52W Chg12.08%
Avg Vol (30d)1.31M
Avg Vol (10d)1.62M
Technical Indicators
RSI (14)50.6
MACD5.7288
MACD Signal6.1652
MACD Hist.-0.4365
BB Upper362.62 USD
BB Middle341.37 USD
BB Lower320.13 USD
BB Width12.45%
ATR (14)8.733 USD
Vol Ratio (20d)1.03x

About Cencora (NYSE: COR)

›

Cencora (NYSE: COR) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Distribution industry, part of the Healthcare sector.

The shares were at 341.25 USD on 19 November 2026, down 5.3% over 52 weeks. Its 52-week range is 244.82 USD to 377.54 USD: the price is 9.6% below the high and 39.4% above the low.

At a market capitalisation of 65.12B USD, it trades at 19.0 times trailing earnings and 15.7 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 23.2, a discount of 18% for COR. It pays a dividend yielding 0.76% (it pays out 17% of its earnings), against a median of 2.55% among the dividend payers in that peer group.

Cencora reports return on equity of 129.0%, an operating margin of 1.4% and revenue up 5.5% year over year.

Its debt exceeds its cash by 6.39B USD, a debt-to-equity ratio of 5.08. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 388.25 USD is 13.8% above the current price. The next earnings report is expected on 3 February 2027.